Dubai – Qahwa World

A recent Italian study published on 19 March 2026 in a scientific journal has found an association between traditional Italian-style coffee consumption and a reduced risk of metabolically dysfunctional-associated steatotic liver disease (MASLD).

The research was conducted by scientists at the National Institute of Gastroenterology in Bari, Italy, and focused specifically on coffee prepared using traditional Italian methods such as espresso and moka, which rely on pressure extraction.

MASLD is currently one of the most widespread chronic liver diseases globally, affecting more than 30% of adults. It is strongly associated with obesity, insulin resistance, type 2 diabetes, dyslipidemia, and hypertension, and can progress to more severe liver conditions, including cirrhosis and liver cancer.

The study analyzed data from a long-term research project in Southern Italy. A total of 1,079 coffee-drinking participants were included in the final analysis. Liver conditions were assessed using ultrasound examinations, while coffee consumption was evaluated through a validated dietary questionnaire.

The findings showed that, after adjusting for various health and lifestyle factors, higher coffee consumption was associated with a lower risk of MASLD. The risk was 52.1% lower among those who consumed one cup per day, 53.2% lower for two cups, and 55.1% lower for three cups. The greatest reduction, 59.3%, was observed among individuals who consumed four to six cups daily.

In addition, each extra cup of coffee per day was associated with an approximate 15.7% reduction in risk.

Researchers attributed these findings to the high levels of bioactive compounds retained in Italian-style coffee, particularly in unfiltered preparations. These include chlorogenic acids, diterpenes, trigonelline, and melanoidins, which are believed to play a role in reducing inflammation, improving insulin sensitivity, and limiting fat accumulation in the liver.

Despite the findings, the researchers emphasized that the study is observational and does not establish a direct cause-and-effect relationship. Coffee consumption was also self-reported by participants.

The study noted that coffee is a central part of daily life in Italy, with most consumers preferring espresso or moka preparation methods.

According to European health guidance, up to 400 mg of caffeine per day is considered safe for healthy adults, though certain groups such as pregnant women or individuals sensitive to caffeine are advised to limit intake.

The study concludes that moderate consumption of Italian-style coffee may be associated with potential liver health benefits, while further research is needed to confirm these findings.